TY - JOUR
T1 - Evolution of disease phenotype in pediatric-onset Crohn's disease after more than 10 years follow up—Cohort study
AU - Rinawi, Firas
AU - Assa, Amit
AU - Hartman, Corina
AU - Mozer Glassberg, Yael
AU - Nachmias Friedler, Vered
AU - Rosenbach, Yoram
AU - Silbermintz, Ari
AU - Zevit, Noam
AU - Shamir, Raanan
N1 - Publisher Copyright:
© 2016 Editrice Gastroenterologica Italiana S.r.l.
PY - 2016/12/1
Y1 - 2016/12/1
N2 - Background Pediatric-onset Crohn's disease (CD) is a heterogeneous disorder which is subjected to progression and complications in a substantial proportion of patients. Aims We aimed to assess the progression in pediatric-onset CD phenotype on long term follow up. Methods Medical charts of pediatric onset CD patients with at least 10 years follow-up were analyzed retrospectively. Disease phenotype was determined at diagnosis and during follow up at different time points. Phenotype was determined according to the Paris classification. The impact of possible predictors on phenotype progression was assessed as well as the association between different therapeutic regimens during disease course and phenotype progression. Results Progression of disease location, behavior, and perianal involvement was observed in 20%, 38% and 20% of patients, respectively, after a median follow-up of 16.4 (±4.4) years. Microscopic ileocolonic disease at diagnosis was significant predictors for progression of disease extent. Treatment with anti tumor necrosis factor-ɑ agents and number of flares per years of follow-up were associated with progression of disease extent, behavior and perianal involvement. Conclusion Disease extent, behavior and prevalence of perianal disease change significantly over time in pediatric-onset CD. In our cohort, most clinical, laboratory and endoscopic parameters do not serve as predictors for long-term disease progression.
AB - Background Pediatric-onset Crohn's disease (CD) is a heterogeneous disorder which is subjected to progression and complications in a substantial proportion of patients. Aims We aimed to assess the progression in pediatric-onset CD phenotype on long term follow up. Methods Medical charts of pediatric onset CD patients with at least 10 years follow-up were analyzed retrospectively. Disease phenotype was determined at diagnosis and during follow up at different time points. Phenotype was determined according to the Paris classification. The impact of possible predictors on phenotype progression was assessed as well as the association between different therapeutic regimens during disease course and phenotype progression. Results Progression of disease location, behavior, and perianal involvement was observed in 20%, 38% and 20% of patients, respectively, after a median follow-up of 16.4 (±4.4) years. Microscopic ileocolonic disease at diagnosis was significant predictors for progression of disease extent. Treatment with anti tumor necrosis factor-ɑ agents and number of flares per years of follow-up were associated with progression of disease extent, behavior and perianal involvement. Conclusion Disease extent, behavior and prevalence of perianal disease change significantly over time in pediatric-onset CD. In our cohort, most clinical, laboratory and endoscopic parameters do not serve as predictors for long-term disease progression.
KW - Crohn's disease
KW - Long-term follow-up
KW - Phenotype progression
UR - http://www.scopus.com/inward/record.url?scp=84994895338&partnerID=8YFLogxK
U2 - 10.1016/j.dld.2016.08.118
DO - 10.1016/j.dld.2016.08.118
M3 - ???researchoutput.researchoutputtypes.contributiontojournal.article???
C2 - 27637153
AN - SCOPUS:84994895338
SN - 1590-8658
VL - 48
SP - 1444
EP - 1450
JO - Digestive and Liver Disease
JF - Digestive and Liver Disease
IS - 12
ER -